Orphan drug designations from the European Medicines Agency (EMA) is the one of the drivers for the development of pipeline drugs of Cushing’s syndrome. Majority of the pipeline drug candidates are being developed using the oral route of administration. Osilodrostat which is being developed by the Novartis AG is in the Phase III stage of development for the treatment of Cushing’s syndrome.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/cushing-syndrome-therapeutics-pipeline-analysis/report-sample
The existing drugs that are developed by the various pharmaceutical companies for the treatment of the disease have demonstrated positive clinical trial results, which in-turn is supporting their further development. For instance, Osilodrostat which is being developed by the Novartis AG demonstrated efficacy and well tolerated in the Phase II proof of concept study for the treatment of the Cushing’s syndrome.
The drug development process involves specific target such as steroid 11-beta-hydroxylase, which is the probable mechanism of action for the treatment of Cushing’s syndrome. Thus, this specific targeted therapy provides opportunities to the companies for better and targeted drug development. Some of the players developing drugs for the treatment of Cushing’s syndrome include Novartis AG, AstraZeneca Plc, Cyclacel Pharmaceuticals, Inc., and Angion Biomedica Corp.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=cushing-syndrome-therapeutics-pipeline-analysis
About P&S Market Research
P&S Market Research is a market
research company, which offers market research and consulting services for various
geographies around the globe. We provide market research reports, industry
forecasting reports, business intelligence, and research based consulting
services across different industry/business verticals.
As one of the top growing market research
agency, we’re keen upon providing market landscape and accurate forecasting.
Our analysts and consultants are proficient with business intelligence and
market analysis, through their interaction with leading companies of the
concerned domain. We help our clients with B2B market research and assist them
in identifying various windows of opportunity, and framing informed and
customized business expansion strategies in different regions.
Contact:
P&S Market Research
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.comWeb: https://www.psmarketresearch.com
No comments:
Post a Comment